FDA Approves Record Number of Novel Drugs in First Half of 2026 Despite Staff Reductions

The U.S. Food and Drug Administration approved 23 new drugs in the first six months of 2026, marking a three-year high for the period. This accelerated pace occurred despite staff cuts implemented in April 2025. The agency's efficiency in drug review appears to have improved, with some approvals fast-tracked through priority programs.